Studies

CellWell record HH-452604

Dysregulation of hepatic deiodinase type I in metabolically associated steatotic liver disease

Nuria López‐Alcántara; Alison-Michelle Naujack; Yingfu Chen; Natalie Taege; Cathleen Geißler; Rebecca Oelkrug; Eva Katrin Wirth; Lutz Schomburg; Anita Boelen; Henriette Kirchner; Jens Mittag

Journal of Molecular Endocrinology · 2025

In plain language

In mice with fatty liver disease, hepatic Dio1 mRNA rose early on a high-calorie diet, but its link to enzyme activity weakened as disease advanced, and raising DIO1 activity did not improve metabolic markers.

Evidence
Emerging
Design
Primary research (design unspecified)

Read it on PubMed

Powered by CellWell

Cite this record: https://thecellwell.org/studies/HH-452604

Produced by the CellWell Research Engine, custom software owned and operated by CellWell. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.

This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.